Zhigao Hu - Publications

Complement inhibition alleviates donor brain death-induced liver injury and posttransplant cascade injury by regulating phosphoinositide 3-kinase signaling.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: April 20, 2022

Tetramethylpyrazine ameliorates hepatic fibrosis through autophagy-mediated inflammation.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: May 09, 2020

FGD1 exhibits oncogenic properties in hepatocellular carcinoma through regulating cell morphology, autophagy and mitochondrial function.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 08, 2019

HIF1α-siRNA and gemcitabine combination-based GE-11 peptide antibody-targeted nanomedicine for enhanced therapeutic efficacy in pancreatic cancers.

Journal: Journal of drug targeting

Published: November 28, 2018

Complement C3 activation regulates the production of tRNA-derived fragments Gly-tRFs and promotes alcohol-induced liver injury and steatosis.

Journal: Cell research

Published: September 01, 2018

MicroRNA-1179 inhibits the proliferation, migration and invasion of human pancreatic cancer cells by targeting E2F5.

Journal: Chemico-biological interactions

Published: April 23, 2018

Bioinformatics analysis of the interactions among lncRNA, miRNA and mRNA expression, genetic mutations and epigenetic modifications in hepatocellular carcinoma.

Journal: Molecular medicine reports

Published: April 18, 2018

Overexpression of Yes-associated protein and its association with clinicopathological features of hepatocellular carcinoma: A meta-analysis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: December 01, 2016

[Corrigendum] Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU.

Journal: Molecular medicine reports

Published: November 14, 2014

Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU.

Journal: Molecular medicine reports

Published: November 14, 2014

[Retracted] Downregulation of δ opioid receptor by RNA interference enhances the sensitivity of BEL/FU drug‑resistant human hepatocellular carcinoma cells to 5‑FU.

Journal: Molecular medicine reports

Published: November 14, 2014